Looking at the prostates of patients with bladder cancer: A thoughtful exercise

BJU International

Volumn 104, Issue 2, 2009, Pages 160-162

  Autorino, Riccardo ^a,b   Di Lorenzo, Giuseppe ^b   Giannarini, Gianluca ^c   Cindolo, Luca ^d   Lima, Estevão ^e   De Sio, Marco ^a   Lamendola, Maria Gaetana ^f   Damiano, Rocco ^g  

^a Clinica Urologica   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY OF PISA   (Italy)

^e Ospedale Civile   (Italy)

^f UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^g UNIVERSITY OF MINHO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

BLADDER CANCER; CANCER STAGING; CANCER SURVIVAL; CYSTECTOMY; HISTOPATHOLOGY; HUMAN; NOTE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE ADENOCARCINOMA; UROGENITAL TRACT CANCER;

HUMANS; INCIDENTAL FINDINGS; MALE; NEOPLASMS, UNKNOWN PRIMARY; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 67650637673     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08476.x     Document Type: Note

References (24)

1. Singh A, Kinoshita Y, Rovito PM et al. Higher than expected association of clinical prostate and bladder cancer. J Urol 2005 173 : 1526 9
2. Singh A, Jones RF, Friedman H et al. Expression of p53 and pRb in bladder and prostate cancer in patients having both cancers. Anticancer Res 1999 19 : 5415 7
3. Amara N, Palapattu GC, Schrage M et al. Prostate stem cell antigen is overexpressed on human transitional cell carcinoma. Cancer Res 2001 61 : 4660 5
4. Saad M, Abdel-Rahim M, Abol-Enein H, Ghoneim MA. Concomitant pathology in the prostate in cystoprostatectomy specimens: a prospective study and review. BJU Int 2008 102 : 1544 50
5. McNeal JE, Redwine EA, Freiha FS et al. Zonal distribution of prostatic adenocarcinoma: correlation with histologic pattern and direction of spread. Am J Surg Pathol 1988 12 : 897 906 (Pubitemid 19011040)
6. Ruffion A, Manel A, Massoud W et al. Preservation of prostate during radical cystectomy: evaluation of prevalence of prostate cancer associated with bladder cancer. Urology 2005 65 : 703 7
7. Revelo MP, Cookson MS, Chang SS, Shook MF, Smith JA Shappell SB. Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery. J Urol 2004 171 : 646 51
8. Montironi R, Mazzucchelli R, Santinelli A, Scarpelli M, Lopez-Beltran A, Bostwick DG. Incidentally detected prostate cancer in cystoprostatectomies: pathological and morphometric comparison with clinically detected cancer in totally embedded specimens. Hum Pathol 2005 36 : 646 54
9. Winkler MH, Livni N, Mannion EM, Hrouda D, Christmas T. Characteristics of incidental prostatic adenocarcinoma in contemporary radical cystoprostatectomy specimens. BJU Int 2007 99 : 554 8
10. Cindolo L, Benincasa G, Autorino R et al. Prevalence of silent prostatic adenocarcinoma in 165 patients undergone cystoprostatectomy: a retrospective study. Oncol Rep 2001 8 : 269 71
11. Lee SH, Chang PL, Chen SM et al. Synchronous primary carcinomas of the bladder and prostate. Asian J Androl 2006 8 : 357 9
12. Damiano R, Di Lorenzo G, Cantiello F et al. Clinicopathologic features of prostate adenocarcinoma incidentally discovered at the time of radical cystectomy: an evidence-based analysis. Eur Urol 2007 52 : 648 57
13. Stamey TA, Freiha FS, McNeal JE, Redwine EA, Whittemore AS, Schmid HP. Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer 1993 71 (Suppl. 3 933 8
14. Barbisan F, Mazzucchelli R, Scarpelli M et al. Urothelial and incidental prostate carcinoma in prostates from cystoprostatectomies for bladder cancer: is there a relationship between urothelial and prostate cancer? BJU Int 2009 (in press)
15. Santinelli A, Mazzucchelli R, Barbisan F et al. alpha-Methylacyl coenzyme A racemase, Ki-67, and topoisomerase II alpha in cystoprostatectomies with incidental prostate cancer. Am J Clin Pathol 2007 128 : 657 66
16. Androulakakis PA, Schneider HM, Jacobi GH, Hohenfellner R. Coincident vesical transitional cell carcinoma and prostatic carcinoma: clinical features and treatment. Br J Urol 1986 58 : 153 6
17. Konski A, Rubin P, Disantagnese PA, Mayer E, Keys H. Simultaneous presentation of adenocarcinoma of prostate and transitional cell carcinoma of bladder. Urology 1991 37 : 202 6
18. Delongchamps NB, Mao K, Theng H et al. Outcome of patients with fortuitous prostate cancer after radical cystoprostatectomy for bladder cancer. Eur Urol 2005 48 : 946 50
19. Rocco B, de Cobelli O, Leon ME et al. Sensitivity and detection rate of a 12-core trans-perineal prostate biopsy: preliminary report. Eur Urol 2006 49 : 827 33
20. Autorino R, Di Lorenzo G, Damiano R et al. Pathology of the prostate in radical cystectomy specimens: a critical review. Surg Oncol 2008 18 : 73 84. Epub 2008 Aug 29
21. Pettus JA, Al-Ahmadie H, Barocas DA et al. Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy. Eur Urol 2008 53 : 370 5
22. Donat SM, Wei DC, McGuire MS, Herr HW. The efficacy of transurethral biopsy for predicting the long-term clinical impact of prostatic invasive bladder cancer. J Urol 2001 165 : 1580 4
23. Ayyathurai R, Gomez P, Luongo T, Soloway MS, Manoharan M. Prostatic involvement by urothelial carcinoma of the bladder: clinicopathological features and outcome after radical cystectomy. BJU Int 2007 100 : 1021 5
24. Palou J, Baniel J, Klotz L et al. Urothelial carcinoma of the prostate. Urology 2007 69 (Suppl. 50 61 (Pubitemid 46186480)